| Structure |
Chemical Name |
CAS |
MF |
 |
Vonoprazan Impurity 57 |
|
|
 |
Tafluprost Impurity 9 |
2099033-66-4 |
C27H41NO8 |
![2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy-](/CAS/20200515/GIF/2253977-80-7.gif) |
2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy- |
2253977-80-7 |
C27H36N2O6 |
![Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester](/CAS/20211123/GIF/1187954-56-8.gif) |
Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester |
1187954-56-8 |
C33H41NO4 |
![N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate)](/CAS/20210111/GIF/1054332-15-8.gif) |
N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate) |
1054332-15-8 |
C19H25F3N7O6PS2 |
![N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide](/CAS/20200611/GIF/2211059-00-4.gif) |
N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide |
2211059-00-4 |
C19H21BrN6O4S |
 |
Isomer 1 of Tazobactam Impurity 3 |
|
|
 |
Ceftiofur USP Impurity I |
|
|
 |
Cephalexin Degradation Impurity A |
|
|
 |
Pregabalin-8687(mixture of 4 isomers) |
|
|
![7-(2-chloropropanoyl)-5H-chromeno[2,3-b]pyridin-5-one](/) |
7-(2-chloropropanoyl)-5H-chromeno[2,3-b]pyridin-5-one |
|
|
![1-(5H-chromeno[2,3-b]pyridin-7-yl)-2-methoxypropan-1-one](/) |
1-(5H-chromeno[2,3-b]pyridin-7-yl)-2-methoxypropan-1-one |
|
|
 |
Dolutegravir Impurity C |
1802141-49-6 |
C22H23F2N3O5 |
 |
Dapoxetine Impurity 68 |
119357-48-1 |
C19H18O |
 |
Tobramycin Impurity |
74501-86-3 |
C18H35N5O8 |
 |
Peramivir Impurity 24 |
|
|
 |
2-CHLORO-6-AMINO-9-(2',3',5'-TRI-O-ACETYL--D-RIBOFURANOSYL)PURINE |
79999-39-6 |
C16H18ClN5O7 |
 |
Sugammadex sodium Impurity 46 |
|
|
 |
(E)-4-chloro-6-(3-(2,4-difluorophenyl)-4-(1H-1,2,4-triazol-1-yl)but-3-en-2-yl)-5-fluoropyrimidine |
|
|
 |
Tenofovir Impurity 103 |
|
|
 |
Cabozantinib impurity 44 |
|
|
 |
Cabozantinib impurity 40 |
|
|
 |
Cabozantinib impurity 74 |
|
|
 |
Doxofylline Impurity 25 |
|
|
 |
Dapoxetine impurity 62 |
|
|
 |
Dapoxetine impurity 56 |
|
|
![N-[4-[[(2,4-ジアミノプテリジン-6-イル)メチル]メチルアミノ]ベンゾイル]-D-グルタミン酸](/CAS/GIF/51865-79-3.gif) |
N-[4-[[(2,4-ジアミノプテリジン-6-イル)メチル]メチルアミノ]ベンゾイル]-D-グルタミン酸 |
51865-79-3 |
C20H22N8O5 |
 |
Bimatoprost Impurity 11 |
|
|
 |
Bimatoprost Impurity 9 |
|
|
 |
Dolutegravir Impurity 18 |
|
|
![3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile](/CAS/20210111/GIF/380918-53-6.gif) |
3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
380918-53-6 |
C23H15N3O |
 |
Lenvatinib Impurity 33 |
|
|
 |
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
 |
Pitavastatin Impurity 71 |
|
|
 |
Rosuvastatin EP Impurity M Sodium Salt |
|
|
 |
Furosemide impurity 8 |
|
|
 |
Febuxostat Impurity 108 |
|
|
 |
Flucloxacillin EP Impurity J |
|
|
![Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester](/CAS/20200611/GIF/1878175-77-9.gif) |
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester |
1878175-77-9 |
C17H23N10O4P |
 |
Hexanoic acid, 3-formyl-, ethyl ester |
54374-02-6 |
C9H16O3 |
 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
 |
Linagliptin Dimer impurity (N-C-C-C Dimer)Q: What is
Linagliptin Dimer impurity (N-C-C-C Dimer) Q: What is the CAS Number of
Linagliptin Dimer impurity (N-C-C-C Dimer) |
2463617-49-2 |
C51H56N16O4 |
![Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-](/CAS/20210111/GIF/906673-43-6.gif) |
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
![1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-](/CAS/20210111/GIF/2138805-26-0.gif) |
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
![1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo-](/CAS/20210111/GIF/1651211-78-7.gif) |
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
 |
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
 |
Vonoprazan Impurity B-2 |
|
|
 |
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
 |
Budesonide Impurity 31 |
|
|
 |
Budesonide Impurity 23 |
|
|
 |
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
 |
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
![2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)-](/CAS/20210111/GIF/1261219-83-3.gif) |
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
 |
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |
 |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
 |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
 |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
 |
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
![3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン](/CAS/GIF/54528-00-6.gif) |
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
 |
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
![(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one](/) |
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
 |
(3R)-3α,4α-(1,3-ジベンジルウレイレン)テトラヒドロチオフェン-5-オン |
28092-52-6 |
C19H18N2O2S |
 |
(2S)-2-ピロリジンカルボン酸メチル |
2577-48-2 |
C6H11NO2 |
 |
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
 |
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |
 |
Oseltamivir Impurity 94 |
|
|
 |
Oseltamivir Impurity 82 |
|
|
 |
Oseltamivir Impurity 74 |
|
|
 |
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
 |
Dapagliflozin Impurity 47 |
|
|
 |
Sitagliptin EP Impurity 7 |
|
|
 |
Sitagliptin EP Impurity H |
|
|
![7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]-](/CAS/20210305/GIF/2636673-48-6.gif) |
7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
2636673-48-6 |
C18H26ClN3O4 |
 |
Beprostatin impurity 4 |
|
|
 |
N-(メトキシカルボニル)-p-トルエンスルホンアミド |
14437-03-7 |
C9H11NO4S |
![(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium](/CAS/20211123/GIF/786598-71-8.gif) |
(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium |
786598-71-8 |
C21H28NO3+ |
 |
(S)-レパグリニドエチルエステル (REPAGLINIDE IMPURITY) |
147770-06-7 |
C29H40N2O4 |
 |
4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride |
152402-97-6 |
C7H8Cl3N |
 |
4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE |
42075-21-8 |
|
![Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]](/CAS/GIF/119699-81-9.gif) |
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] |
119699-81-9 |
C48H94N2O14Si2 |
 |
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
 |
Isavuconazole Impurity 37 |
|
|
![N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide](/CAS/20210305/GIF/1375004-39-9.gif) |
N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
1375004-39-9 |
C29H39BN4O4 |
 |
(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |
|
|
 |
Mannitol EP impurity B |
|
|
 |
Mannitol EP impurity A |
|
|
 |
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
 |
Peramivir Chlorinated Impurity |
|
|
 |
Brivaracetam Impurity 999 |
|
|
 |
Dasatinib impurity 48 |
|
|
 |
Pemetrexed Impurity 120 |
|
|
 |
Ticagrelor Impurity 101 |
|
|
![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](/) |
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|
 |
1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride |
2137793-92-9 |
|
 |
(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97% |
103765-03-3 |
C4H11ClN2O |
 |
Flomoxef Impurity 20 Sodium Salt |
2095697-77-9 |
C15H18F2N6O7S2 |
 |
((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
2591381-21-2 |
C9H16O6 |
amino]-5-(4-nitrophenyl)-, ethyl ester](/CAS/20210305/GIF/2591260-07-8.gif) |
3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester |
2591260-07-8 |
C25H23BrF2N2O6S |
![Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel-](/CAS/20210305/GIF/190582-37-7.gif) |
Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- |
190582-37-7 |
C23H32N4O3S |